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Caspase-1 Activation of IL-1b
and IL-18 Are Essential
for Shigella flexneri±Induced Inflammation
products of Casp-1, IL-1b, and IL-18 are proinflamma-
tory cytokines (Dinarello, 1998), although apoptosis is
often immunologically silent and does not cause inflam-
mation (Savill, 1997).
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Eventually, however, the inflammation eradicates Shi-Japan
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Shigella invades host cells by macropinocytosis
Summary (Adam et al., 1995) and quickly escapes from phago-
somes into the cytoplasm (Sansonetti et al., 1986). In
Caspases are intracellular proteases that mediate contrast to epithelial cells, which allow Shigella to multi-
mammalian cell apoptosis. Caspase-1 (Casp-1) is a ply in their cytoplasm, macrophages undergo apopto-
unique caspase because it activates the proinflamma- sis after bacterial uptake (Zychlinsky et al., 1992). The
tory cytokines interleukin (IL)-1b and IL-18. Shigella upregulation of apoptosis was demonstrated in animal
flexneri, the etiological agent of bacillary dysentery, models of Shigella infection (Zychlinsky et al., 1996) and
induces macrophage apoptosis, which requires Casp-1 in intestinal biopsies from dysenteric patients (Islam et
and results in the release of mature IL-1b and IL-18. al., 1997). The invasion plasmid antigen (Ipa) B is a pro-
Here we show that casp-12/2 mice infected with S. tein encoded in the Shigella virulence plasmid that is
flexneri do not develop the acute inflammation charac- secreted from bacteria through a type III secretion appa-
teristic of shigellosis and are unable to resolve the bacte- ratus. IpaB alone is sufficient to induce apoptosis (Chen
rial infection. Using casp-12/2 mice supplemented with et al., 1996). IpaB binds to Casp-1 in the macrophage
recombinant cytokines and experiments with IL-1b2/2 cytosol and activates an apoptotic cascade (Chen et
and IL-182/2 mice, we show that IL-1b and IL-18 are al., 1996; Thirumalai et al., 1997). Interestingly, macro-
both required to mediate inflammation in S. flexneri phages isolated from mice with a targeted deletion in
infections. Together, these data demonstrate the im- casp-1 but not from casp-3 or casp-11 null mice are
resistant to Shigella-induced apoptosis (Hilbi et al.,portance of Casp-1 in acute inflammation and show
1998). Thus, unlike most other apoptotic stimuli, Shi-the different roles of its substrates, IL-1b and IL-18,
gella-induced apoptosis in macrophages requires Casp-1.in this response.
Here we demonstrate that Casp-1 is essential for the
inflammation provoked by Shigella. Shigella causes an
Introduction inflammatory response of the lung tissue of mice that
parallels the acute inflammation in the intestinal mucosa
Caspase-1 (Casp-1), like all caspases, is a cysteine pro- of dysenteric patients, when administered intranasally
tease that induces apoptosis when overexpressed in (Voino-Yasenetsky and Voino-Yasenetska, 1961; Phali-
cultured cells (Miura et al., 1993). However, unlike mice pon et al., 1995). We use this model of infection because
with targeted deletions in most other caspase genes, Shigella cannot infect mice orally. Wild-type mice de-
casp-12/2 mice do not have any developmental defects, velop a severe inflammatory response within 6 hr of
and cells isolated from these animals respond normally infection. The bacterial load diminishes over time and
to ªclassicalº apoptotic stimuli (Kuida et al., 1995; Li et the inflammation starts to resolve 48 hr later. In contrast,
al., 1995), suggesting that Casp-1 causes apoptosis only casp-12/2 mice do not generate an inflammation in re-
on dysregulated activation. In addition, the cleavage sponse to a Shigella infection until much later. Moreover,
the inflammation that eventually develops in casp-12/2
mice is more severe than the acute inflammation in wild-k To whom correspondence should be addressed (e-mail: zychlins@
saturn.med.nyu.edu). type mice. Even after extended periods of infection,
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at later time points. In wild-type mice, there was a signifi-
cant drop in the number of bacteria recovered 24 hr
(p 5 0.0039) after infection, and by 96 hr bacterial recov-
ery was reduced by three orders of magnitude. In con-
trast, 24 and 48 hr after infection, casp-12/2 mouse lungs
had 10- and 670-fold more bacteria than wild-type mice,
respectively (p 5 0.0011). casp-12/2 mice still harbored
a large number of bacteria even at 96 hr postinfection.
Mice with a targeted deletion in casp-1 succumbed
to the Shigella infection. As shown in Figure 1B, there
were a few wild-type mice that died early on after infec-
tion. In contrast, the mortality of casp-12/2 mice in-
creased during the experiment. Together, these data
show that wild-type but not casp-1 null mice are able
to efficiently control the microbial infection.
Shigella Does Not Upregulate Apoptosis
in casp-12/2 Mice
To determine whether Shigella induces apoptosis in this
infection model, we labeled sections of infected lung
tissue by the terminal d-transferase dUTP nick end label-
ing (TUNEL) technique. In histopathological sections
taken at 6 hr after infection, we observed apoptotic cells
that had a macrophage morphology in wild type (Figures
2A±2C), but we did not see apoptosis in casp-12/2 mice
(Figures 2D±2F).
Reconstruction of complete sections of lungs from
wild-type (Figures 2I and 2J) and casp-12/2 (Figures 2G
and 2H) mice demonstrated a striking difference in the
number of TUNEL-positive cells. Many apoptotic cells
were present in the middle portion of the wild-type lungFigure 1. casp-12/2 Mice Cannot Control Shigella Infections
with greatest density around the bronchi, mirroring the(A) The number of bacteria in the lungs of wild-type (open circles)
distribution of bacteria. Very few apoptotic cells wereand casp-12/2 (closed circles) mice are presented as the mean and
detected in the lungs of casp-12/2 mice. These apoptoticstandard error of the number of colony-forming units. Six hours after
infection, there were similar numbers of bacteria in wild type and cells localized to the periphery of the tissue. A similar
casp-12/2 mice. The number of bacteria significantly decreased in distribution of apoptotic cells was observed in unin-
wild-type animals starting as early as 24 hr and continuing up to 96 fected lungs or lungs infected with S. flexneri strain with
hr. In casp-12/2 mice, the bacterial load increased slightly by 24 hr
a targeted deletion in ipaB (DipaB, data not shown),and remained unresolved even at 96 hr postinfection.
suggesting that this was a phenomenon unrelated to(B) Wild-type (open circles) and casp-12/2 (closed circles) mice were
shigellosis. Thus, in vivo, Shigella requires Casp-1 toinfected with Shigella and their survival recorded for 96 hr. In con-
trast to wild-type mice, casp-1 null mice were susceptible to Shigella induce apoptosis.
especially 48 hr after infection.
Inflammation in Shigella Infections
of casp-12/2 Mice
casp-12/2 mice are unable to control the infection and To determine the role of Casp-1 in inducing an inflamma-
the inflammation continues to worsen. We demonstrate tory response, we evaluated the extent of tissue inflam-
that IL-1b is the Casp-1 substrate responsible for the mation in casp-12/2 mice by histopathological analysis.
intensity of the acute inflammation observed in Shigella A qualitative analysis of a selection of typical histopatho-
infections, while the other substrate, IL-18, is important logical aspects is shown in Figure 3. In wild-type mice,
in eliciting an effective anti-bacterial response. There- extensive inflammation is observed at 6 hr in the peri-
fore, in vivo activation of Casp-1 by Shigella is proinflam- bronchial/bronchiolar area and in the pulmonary tissue,
matory. causing acute diffuse alveolitis (Figure 3A). At 24 hr,
inflammation is less extensive; alveolar walls remain
thickened but the alveolitis is already resolving (FiguresResults
3B and 3C). By 48 hr, the overall alveolar structure has
almost returned to normal, with a few remaining macro-Bacterial Load and Mortality in Shigella Infections
of casp-12/2 and Wild-Type Mice phages and PMN (Figure 3D). Although a persistent
edema still thickens the alveolar walls, the tissue hasTo evaluate the in vivo role of Casp-1 in Shigella infec-
tions, we infected casp-12/2 and wild-type mice with a almost recovered. The disappearance of inflammatory
cells at 96 hr (Figure 3E) shows the complete regressionsublethal dose of bacteria intranasally. The number of
bacteria in the lungs of infected wild-type and casp-12/2 of the inflammation.
The pathology is strikingly different in casp-12/2 ani-mice after 6 hr of infection was not statistically different
(p 5 0.59) (Figure 1). However, a difference was manifest mals. Very few inflammatory foci are observed at 6 hr
Casp-1 and Inflammation in Shigella Infections
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Figure 2. Shigella Induces Macrophage Apoptosis in Wild-Type but Not in casp-12/2 Infected Mice
(A) Two cells with macrophage morphology (arrowheads) were identified in wild-type mice in a section stained with hematoxilin and eosin
(H&E) stain.
(B) The same cells were labeled with an anti-LPS antiserum (arrows) indicating that they are infected with S. flexneri.
(C) The same two cells were positively stained by fluorescent TUNEL (arrows). Thus, we were able to identify infected macrophages undergoing
apoptosis in these animals.
(D and E) H&E-stained macrophages (arrowheads) of casp-1 null mice were also labeled with anti-LPS serum (E), indicating that they were
infected.
(F) These same cells were not stained by TUNEL, showing that in vivo casp-12/2 macrophages do not undergo apoptosis with Shigella.
(G) Reconstruction of a section from a lung from a casp-12/2 mouse infected with S. flexneri and stained with fluorescent TUNEL. Few cells
toward the edge of the lung were labeled, serving as a positive control.
(H) Reconstruction of the same section shown in (G) stained with the DNA stain propidium iodide that allows the visualization of the complete
lung section.
(I) Reconstruction of a lung from a wild-type mouse infected with S. flexneri and stained with fluorescent TUNEL. Large numbers of TUNEL-
positive cells are evident in the middle portion of the lung, with a greater concentration in close proximity to bronchi, a distribution similar to
that of bacteria.
(J) Reconstruction of the same section shown in (I) and stained with propidium iodide. Scale bars in (A±F) are 10 mm. Scale bars in (G±J) are
1 mm.
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Figure 3. Inflammation in the Lungs of Wild-Type and casp-12/2 Mice Infected with S. flexneri
Lungs of infected mice were processed for histopathological analysis and stained with H&E.
(A) Wild-type mice 6 hr after infection show extensive inflammation, starting in the peribronchial region and spreading through the lung,
causing acute diffuse alveolitis.
(B) In wild-type mice 24 hr after infection, the inflammation is starting to resolve.
(C) High magnification of (B) showing some thickened alveolar walls.
(D) Forty-eight hr after infection some mononuclear cells are still observed in thickened alveoli in wild-type mice.
(E) Ninety-six hours postinfection the lung has almost normal morphology.
(F) Wild-type mice 24 hr after infection with DipaB do not show any signs of inflammation.
(G) casp-12/2 mice 6 hr after infection present very few inflammatory sites concentrated in the peribronchial and bronchiolar areas, without
significant acute condensing alveolitis.
(H) At 24 hr postinfection there is a strong diffuse inflammation with formation of multiple foci of acute condensing alveolitis.
(I) Higher magnification of (H) showing intense inflammation and many bronchi and bronchioli occluded by inflammatory exudates in casp-1
null mice.
(J) Forty-eight hours after infection casp-12/2 mice still show condensing inflammation with edema and emphysema.
(K) The inflammation, edema, and emphysema are unabated 96 hr postinfection. Strong hemorrhagic necrosis is also evident at this late time
point.
(L) casp-1 null mice 24 hr after infection with DipaB without any sign of inflammation. Scale bars, 30 mm.
(Figure 3G). However, 24 hr after infection, there is a scanned at high resolution onto a computer. Using im-
age analysis, we measured the area of the tissue sec-strong diffuse inflammation with extensive areas of alve-
olitis. Many bronchi and bronchioli are occluded by a tions which had a high color density and granularity.
Because of its structure, a healthy lung has very fewmassive inflammatory exudate (Figure 3H and 3I). By 48
hr postinfection (Figure 3J), the tissue damage worsens areas with high color density, while an inflamed lung,
where the alveoli are infiltrated with inflammatory cells,as condensing lesions predominate with tissue necrosis
and hemorrhages. Ninety six hours after inoculation (Fig- has large areas with high color density. The ratio of the
high color density surface to the entire surface of theure 3K), the histopathology remains the same: large ar-
eas of condensing inflammation, often centering around tissue section, excluding the anatomic ªholesº (i.e.,
the lumen of large blood vessels and bronchi) yields anvessels occluded with mononuclear cells, and areas
with hemorrhages and necrotic tissue. The inflammation ªinflammatory indexº (IF). This measure underestimates
the inflammation, since it is biased toward well-deline-in casp-12/2 mice was richer in macrophages than in
wild-type mice. ated and condensed foci, omitting diffuse noncondens-
ing processes. The analysis showed that by 6 hr, wild-typeThere were no lesions observed in either wild type or
casp-12/2 mice infected with DipaB either at 6 hr (data mice developed an IF of 15.0, whereas the casp-12/2
mice had an IF of 0.80, indicating a lack of an inflamma-not shown) or 24 hr (Figures 3F and 3L).
In order to quantify the severity of inflammation, lung tory response in the latter. The inflammation decreased
in wild-type animals at 24 and 48 hr and reached an IF ofsections stained by hematoxilin and eosin (H&E) were
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Figure 4. Distribution of LPS in Lungs of
Wild-Type and casp-12/2 Mice Infected with
Virulent S. flexneri
Lungs of infected mice were processed for
histopathological analysis using standard
techniques and immunostained with an anti-
S. flexneri serotype 5 LPS-specific antiserum.
(A and B) Wild-type mice 6 hr after infection
present large amounts of LPS throughout the
lung, particularly in association with areas of
acute alveolitis. Inset shows a section stained
with an isotype control mAb (B) and demon-
strates the specificity of the immunostaining.
(C and D) Wild-type mice 24 hr after infection
display diffuse localization of LPS, which is
more abundant in bronchial/bronchiolar walls.
(E and F) In casp-12/2 mouse 6 hr after infec-
tion LPS is diffusely distributed in the lung
and is more prominent in the lumen and walls
of bronchi and bronchioli.
(G and H) casp-1 null mice 24 hr after infection
show massive amounts of LPS that fill luminal
spaces and are associated with inflammatory
cells. Scale bars, 300 mm.
only 3.6 by 96 hr. In contrast, casp-12/2 mice experi- in casp-12/2 mice 24 hr after infection were unchanged
from 6 hr. These results are in agreement with the dataenced a striking increase in the intensity of their lesions
by 24 hr when they achieved an IF of 12.5, which contin- on the number of colony-forming units in the lungs of
wild-type and casp-12/2 mice presented in Figure 1.ued to increase to almost 40 by 48 hr and 96 hr. The
inflammation seen in the wild-type lungs was signifi-
cantly different from casp-12/2 at each time point (p 5 Recombinant IL-1b Exacerbates the Infection While
IL-18 Restores the Wild-Type Phenotype,0.001).
We used a serotype-specific anti-LPS monoclonal an- in casp-1 Null Mice
Casp-1 activates the proinflammatory cytokines IL-1btibody to determine the distribution of bacteria in the
infected tissue. As shown in Figure 4, Shigella were and IL-18 (Dinarello, 1998). To test the roles of IL-1b
and IL-18 individually in inflammation during Shigellapresent throughout the middle portion of the lung sec-
tion 6 hr postinfection. The LPS immunostaining was infection, we injected casp-12/2 mice intraperitoneally
with either recombinant IL-1b or IL-18 and sacrificed thespecific, since a control with an isotype-matched mono-
clonal did not stain the tissue (Figure 4B, inset). The mice 48 hr postinfection. Shigella-infected casp-12/2
mice presented the previously described phenotype ofbacteria were found in more defined foci at 24 hr in the
lungs of wild-type mice. Although there was almost no condensing inflammation with defined areas of infection
(Figures 5A and 5B). Treatment with recombinant IL-inflammation in the lungs of casp-12/2 mice at 6 hr post-
infection, there were areas in the lungs that were occu- 1b resulted in a more diffuse and severe inflammatory
response and a more dispersed distribution of bacteriapied by bacteria. The distribution and amount of bacteria
Immunity
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Figure 5. Recombinant IL-1b and IL-18 Have
Different Functions in Shigella Infections
casp-1 null mice were either mock treated or
treated with recombinant IL-1b or IL-18 as
described in Experimental Procedures and
infected with Shigella for 24 hr. The tissue
was processed either for H&E staining or im-
munostaining with an anti-Shigella serotype
5 mAb.
(A and B) Control casp-1 null mice show a
strong diffuse inflammation with formation of
multiple foci of acute condensing alveolitis
and (B) large amounts of LPS.
(C and D) casp-12/2 mice treated with IL-1b
show a similar, if slightly increased, inflamma-
tion and (D) abundant LPS staining.
(E and F) In contrast, casp-1 null mice injected
with recombinant IL-18 show a decreased
nondiffuse inflammation (arrows) (F) and the
corresponding localization of LPS.
in the lungs of these mice (Figures 5C and 5D). In con- 0.04) fold more bacteria than wild-type mice, respec-
tively. Thus, similar to casp-12/2 mice, IL-182/2 micetrast, treating casp-12/2 mice with recombinant IL-18
decreased the inflammation and restricted the distribu- could not control the Shigella infection.
Figure 7 shows the LPS immunostaining of wild-type,tion of the bacteria to a similar degree to that observed
in wild-type mice (Figures 5E and 5F). lL-1b null, and IL-18 null mice at 24 and 48 hr postinfec-
tion. Lungs from wild-type mice showed a restrictedThe enumeration of bacteria in the lungs of these mice
corroborated the histological observations. At 48 hr
wild-type mice were resolving the infection (7.2 3 103 6
4.5 SD cfu/lung) while casp-1 null mice were still heavily
infected (110 3 103 6 4.5 SD, p 5 0.01), as observed
earlier. Surprisingly, at the same time point, casp-1 null
mice injected with recombinant IL-1b presented an even
higher number of bacteria (966 3 103 6 526), that was
significantly greater (p 5 0.01) than seen in untreated
casp-12/2 mice. In contrast, administration of recombi-
nant IL-18 resulted in a bacterial load (18 3 103 6 16.3)
that was not different from wild-type mice (p 5 0.7).
Infection of IL-1b and IL-18 Null Mice
Macrophages from both IL-1b null and IL-18 null mice
are susceptible to Shigella-induced apoptosis (data not
shown). Thus, neither of these cytokines is necessary
in the Casp-1-dependent apoptotic pathway. To deter-
mine downstream effectors of Casp-1-mediated inflam- Figure 6. IL-18 but Not IL-1b Is Required to Control Shigella In-
mation in response to Shigella, we infected IL-1b2/2 fection
and IL-182/2 mice with these bacteria. The number of The number of bacteria in the lungs of wild-type (open circles) and
IL-1b2/2 (A) or IL-182/2 (B) (closed circles) mice are presented asbacteria in wild-type and IL-1b2/2 mice was not signifi-
the mean and standard error of the number of colony-forming units.cantly different at 6, 24, or 48 hr postinfection (Figure 6A).
Six hours after infection, there were similar numbers of bacteria inIn contrast, although the level of infection was similar at
wild-type and either IL-1b null or IL-18 null mice infected with Shi-6 hr between IL-18 null and wild-type mice, IL-18 null
gella. The number of bacteria was similar in wild-type and IL-1b2/2
mice did not control the infection at later time points mice at later times after infection. In contrast, the bacterial load
(Figure 6B). Twenty four and 48 hr after infection, the increased slightly by 24 hr and was higher than wild type by 48 hr
in IL-18 null mice.lungs of IL-182/2 mice had 61 (p 5 0.02) and 1150 (p 5
Casp-1 and Inflammation in Shigella Infections
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Figure 7. IL-1b and IL-18 Have Distinct Roles
in the Acute Inflammation Characteristic of
Shigellosis
The distribution of LPS and inflammation in
lungs of wild-type, IL-1b null, and IL-18 null
mice infected with virulent S. flexneri is visual-
ized using standard histopathological tech-
niques and immunostaining with an anti-S.
flexneri serotype 5 LPS-specific mAb.
(A) In wild-type mice 24 hr after infection, the
inflammation is starting to resolve and there
is a diffuse localization of LPS, which is more
abundant in bronchial/bronchiolar walls.
(B) Forty-eight hours after infection, wild-type
mice show a clear resolution of the inflamma-
tion and a decrease in LPS staining.
(C) Mice with a targeted deletion in IL-1b
show a diffuse inflammation at 24 hr.
(D) This inflammatory response increases and
LPS is abundant at 48 hr.
(E) In contrast, IL-18 null mice show a very
intense inflammation with abundant LPS
staining at 24 hr.
(F) Forty eight hours after infection, the IL-
182/2 mice show an unabated inflammation
rich in LPS staining, reminiscent of the phe-
notype of casp-1 null mice.
bacterial distribution with occlusion of a few bronchi at 1998). These data probably reflect the fact that IpaB
binds to Casp-1 and not to other caspases (Hilbi et al.,24 hr postinfection and a diminution in both inflamma-
tion and the amount and distribution of LPS. This pro- 1998). The requirement for Casp-1 in Shigella-induced
apoptosis allowed us to study the proinflammatory func-gression was similar to the one already described in
Figures 3 and 4. Mice with a targeted deletion in IL-1b tions of this caspase in Shigella infection.
Shigella is an invasive bacteria that triggers an acuteshowed a more localized inflammation than wild-type
mice at 24 hr. This inflammatory response did not appear inflammation that eliminates the infection in humans.
The murine lung model of infection mimics the invasiveto progress toward resolution at 48 hr. Consistent with
the results obtained from infection of casp-1 null mice and proinflammatory properties of S. flexneri in the hu-
man intestinal mucosa. When mice are inoculated intra-treated with recombinant IL-18, mice with a targeted
deletion in IL-18 showed a very intense inflammation at nasally, shigellae invade the tracheobronchial and alve-
olar epithelia. An acute tracheobronchitis and alveolitis24 hr, with diffuse LPS staining, reflecting the spread of
Shigella. At 48 hr postinfection, the inflammation was characterized by a massive influx of PMN results from
the infection (Voino-Yasenetsky and Voino-Yasenetska,more severe, with several bronchi occluded and a con-
tinued diffuse distribution of LPS. Thus, the patterns of 1961; Phalipon et al., 1995). Furthermore, mice, like hu-
mans, are able to control the Shigella infection. Noninva-infection and inflammation in casp-1 and IL-18 null mice
were similar. sive mutants of Shigella such as the DipaB strain, used
as a control in this study, do not cause pulmonary pa-
thology (Phalipon et al., 1995), confirming the validity ofDiscussion
the model.
Mice with a targeted deletion in casp-1 were unableSevere intestinal inflammation is a hallmark of bacillary
to generate an early inflammation (6 hr) or resolve thedysentery. Therefore, to understand the pathogenesis
infection (Figures 1A and 4) and eventually succumbedof dysentery, it is crucial to determine how the bacteria
to the infection significantly more frequently (Figure 1B)activate this inflammatory response. In vivo, Shigella
than wild-type mice. Interestingly, at later time points,induces apoptosis in a rabbit ileal loop model (Zychlin-
the lungs of casp-12/2 mice develop more severe inflam-sky et al., 1996), in dysenteric patients (Islam et al.,
mation than that in wild-type mice. Monocytes, rather1997), and in the murine lung infection model (Figure 2).
than PMN, dominated the inflammatory response inShigella-induced apoptosis appears to initiate a unique
casp-12/2 mice. In order to test the induction of a proin-cell death pathway, since, in contrast to other apoptotic
flammatory cytokine not dependent in Casp-1 activa-stimuli (Li et al., 1995), Shigella does not induce apopto-
sis in macrophages from casp-12/2 mice (Hilbi et al., tion, we tested the concentration of IL-6 in the serum
Immunity
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of infected animals. At 6 hr postinfection, the levels of Given the rapid inflammatory response to Shigella, it
IL-6 were similar in casp-12/2 and wild-type mice (data would be surprising if IL-18 was acting solely as an
not shown), indicating that Casp-1-independent proin- IFNg-inducing factor. In fact, IL-18 seems to have IFNg-
flammatory mechanisms were active in casp-1 null mice. independent proinflammatory functions (Kohka et al.,
Furthermore, the distribution of Shigella seems to be 1998; Shapiro et al., 1998). More detailed studies on the
more restricted in casp-12/2 than in wild-type mice (Fig- early events of infection using IFNg null mice will further
ure 4). Shigella is a nonmotile organism that uses the delineate the functions of IL-18 in Shigella infections.
host cell cytoskeleton to move from cell to cell (Bernar- IL-1b is essential in the innate immune response to
dini et al., 1989). Therefore, it is possible that in wild- many different microbial pathogens (Dinarello, 1998),
type mice, but not in casp-12/2 nulls, Shigella spreads and recently IL-18 was also shown to be crucial in the
more efficiently after tissue disruption by the inflamma- immune response to Mycobacterium tuberculosis (Su-
tory response. casp-12/2 mice could not eradicate the gawara et al., 1999), Salmonella typhimurium (Mastroeni
Shigella infection (Figures 1 and 4), suggesting that only et al., 1999), Yersinia enterocolitica (Bohn et al., 1998),
Casp-1-mediated inflammation could effectively clear Leishmania major, and in sequelae to Staphylococcus
the bacteria. Interestingly, there were 2-fold higher lev- aureus (Wei et al., 1999). The mechanisms of IL-1b and
els of serum IL-6 in casp-12/2 than in wild-type mice, IL-18 activation in these infections, except in Salmo-
probably reflecting the persistence of the infection (data nella, are not yet clear. Salmonella encodes SipB, a
not shown). These data indicate that the host requires homolog of IpaB that activates Casp-1 (Hersh et al.,
Casp-1 to mount the inflammatory response character- 1999). Recently Casp-1 was shown to be essential for
istic of shigellosis. Future investigation will determine the progression of salmonellosis in vivo (Monack et al.,
whether the timing or the type of cell recruited in the unpublished data). It remains to be determined whether
inflammation is important for the eradication of Shigella. Casp-1-mediated inflammation through IL-1b and IL-18
Both IL-1b and IL-18 are synthesized as inactive pre- is a common pathway in other microbial infections.
cursors that lack a secretion signal sequence and are The data presented here directly link the bacterial
proteolytically activated by Casp-1 (Thornberry et al., virulence factor IpaB with the initiation of inflammation
1992; Ghayur et al., 1997; Gu et al., 1997). We used two through Casp-1. We propose that Casp-1 is a compo-
independent approaches to test the roles of IL-1b and nent of the innate immune response. Invasion of macro-
IL-18 in Shigella infections; casp-12/2 mice reconstitu- phages by Shigella directly activates Casp-1, which trig-
ted with recombinant IL-1b or IL-18 as well as IL-1b null gers an acute inflammation by proteolytically activating
and IL-18 null mice. Recombinant IL-1b enhanced both IL-1b and IL-18. It remains to be determined whether
the inflammatory response and, more importantly, the induction of apoptosis is necessary to allow the rapid
bacterial infection load in casp-1 null mice challenged release of these two cytokines. Thus, Casp-1 might have
with Shigella (Figure 5). Consistent with this notion, in- coevolved with the virulence factors of acute pathogens
fection of IL-1b2/2 mice resulted in an inflammatory pro- such as Shigella. In this model, Casp-1 emerges as a
cess that was more localized than in wild-type mice and protease that coordinates the use of an apoptotic path-
that restricted the distribution of bacteria to the sites of way to release mature cytokines.
entry more effectively than wild-type mice (Figure 7).
These mice, however, progressed toward the resolution Experimental Procedures
of the infection (Figure 6). It has been proposed that the
destruction of the tissue by the initial inflammation in Bacteria and Growth Conditions
M90T, an invasive isolate of S. flexneri serotype 5, was our virulentresponse to Shigella allows further bacterial infection
strain of reference (Sansonetti et al., 1981). An IpaB deletion mutant(Perdomo et al., 1994). These data would be consistent
of M90T referred to as DipaB was used as a negative control (MeÂ nardwith the hypothesis that IL-1b is involved in the initial
et al., 1993). Bacteria were routinely grown in Luria Broth at 378C
inflammatory response to Shigella and invasion into the with aeration. The bacteria were washed and resuspended in RPMI
lungs, and that in the absence of this cytokine, the infec- for macrophage infection and in PBS for mouse infections.
tious foci are more restricted than in wild-type mice.
Indeed, IL-1b is induced and activated very early after Mice
Shigella infection (Arondel et al., 1999) and blocking casp-12/2 mice were obtained from the Animal Resource Facility at
BASF Bioresearch Corporation (Li et al., 1995). IL-1b2/2 mice wereIL-1 with IL-1 receptor antagonist (IL-1ra) decreases the
obtained from Merck (Zheng et al., 1995), and IL-182/2 mice (Takedainflammation in the rabbit ileal loop model (Sansonetti
et al., 1998) were obtained from Dr. Kiyoshi Takeda at Osaka Univer-et al., 1995).
sity. Animals were housed at the Institut Pasteur or NYU MedicalRecombinant IL-18 reconstituted a wild type inflam-
Center animal facility. casp-1 and IL-18 null mice are C57BL/6, and
matory response in casp-12/2 mice (Figure 5). The role IL-1b2/2 mice are in the I29 Sv background. All three null strains
of IL-18 in Shigella infections was corroborated by the were backcrossed at least eight times and were controlled with the
IL-182/2 mice infected with Shigella, which did not regu- appropriate isogenic mice. The course of the Shigella infection is
indistinguishable in mice with different genetic background (P. J. S.late the inflammation nor control the bacterial growth
et al., unpublished data). Control mice were obtained from the UniteÂ(Figures 6 and 7), a phenotype similar to that observed
de GeÂ neÂ tique Murine and Central Animal Facility at the Institutin casp-1 null mice. Taken together, these data show
Pasteur.that IL-18 is required to generate an inflammatory re-
sponse capable of eradicating Shigella effectively. IL-
Treatment with Recombinant Cytokines
18 induces IFNg and activates a TH1 response (reviewed Mice were injected intraperitoneally with 0.5 mg/mouse mature mu-
in Dinarello, 1998). Interestingly, Way et al. showed that rine recombinant IL-1b (Cirulli et al., 1998; Neveu et al., 1998) and
IFNg-deficient mice were significantly more susceptible 10 mg/mouse IL-18 (both cytokines from Biosource International,
CA) at the infection time and every 24 hr thereafter. These protocolsto Shigella infection at later time points (Way et al., 1998).
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have been shown to be effective in other systems (Kawakami et al., Bernardini, M.L., Mounier, J., d'Hauteville, H., Coquis-Rondon, M.,
and Sansonetti, P. J. (1989). Identification of icsA, a plasmid locus1997; Cirulli et al., 1998; Neveu et al., 1998).
of Shigella flexneri that governs bacterial intra- and intercellular
spread through interaction with F-actin. Proc. Natl. Acad. Sci. USAMice Infection and Bacterial Counts
86, 3867±3871.Mice were inoculated intranasally with 2 3 108 bacteria in 20 ml as
described (Phalipon et al., 1995). For bacterial enumeration, the Bohn, E., Sing, A., Zumbihl, R., Bielfeldt, C., Okamura, H., Kurimoto,
mice were sacrificed at the indicated time points and the lungs were M., Heesemann, J., and Autenrieth, I.B. (1998). IL-18 (IFN-gamma-
rapidly removed ªen blocº and ground in 10 ml sterile PBS (Ultra inducing factor) regulates early cytokine production in, and pro-
Turrax T25 apparatus, Janke and Kunkel IKA Labortechnik GmbH, motes resolution of, bacterial infection in mice. J. Immunol. 160,
Staufen, Germany). Dilutions were then plated on Trypticase Soy 299±307.
Broth plates for cfu enumeration. Each data point is the mean of at Chen, Y., Smith, M.R., Thirumalai, K., and Zychlinsky, A. (1996). A
least 10 (range 10±12) infected mice per group from two independent bacterial invasin induces macrophage apoptosis by binding directly
experiments. Susceptibility to Shigella infections was done in to ICE. EMBO J. 15, 3853±3860.
groups of at least 16 animals.
Cirulli, F., De Acetis, L., and Alleva, E. (1998). Behavioral effects of
peripheral interleukin-1 administration in adult CD-1 mice: specificTUNEL
inhibition of the offensive components of intermale agonistic behav-Terminal d-transferase dUTP nick end labeling (TUNEL) was done
ior. Brain Res. 27, 308±312.using the Apoptosis Detection System, Fluoresceine kit (Promega,
Dinarello, C. (1998). Interleukin-1û, Interleukin-18, and the Interleu-Madison, WI). For double-labeling experiments, the sections were
kin-1 beta converting enzyme. Ann. N.Y. Acad. Sci. 856, 1±11.first labeled with ant-LPS antiserum as described (Sansonetti et al.,
1996), then labeled with TUNEL and mounted in 50% glycerol in Ghayur, T., Banerjee, S., Hugunin, M., Butler, D., Herzog, L., Carter,
PBS. After photographing the LPS label by light microscopy and A., Quintal, L., Sekut, L., Talanian, R., Paskind, M., et al. (1997).
the TUNEL label with epifluorescence, the sections were washed, Caspase-1 processes IFN-gamma-inducing factor and regulates
stained with H&E, dehydrated, and mounted in Permount. The same LPS-induced IFN-gamma production. Nature 386, 619±623.
field that was photographed for LPS and TUNEL labeling was local- Gu, Y., Kuida, K., Tsutsui, H., Ku. G., Hsiao, K., Okamura, H., Nakani-
ized and photographed again. To reconstitute the TUNEL and pro- shi, K., Kurimoto, M., Tanimoto, T., Flavell, R.A., et al. (1997) Activa-
pidium iodide label in a whole section, each field was scanned with tion of interferon-g inducing factor mediated by interleukin-1û con-
a confocal microscope (Molecular Dynamics, Sunnyvale, CA) in both verting enzyme. Science 275, 206±209.
channels. The sections were reconstructed using Adobe Photoshop.
Hale, T.L. (1991). Genetic basis of virulence in Shigella species.
Microbiol. Rev. 55, 206±224.Histopathological Studies
Hersh, D., Monack, D., Smith, M., Ghori, N., Falkow, S., and Zychlin-At the indicated time points, the mice were anesthetized, their tra-
sky, A. (1999). The Salmonella invasin SipB induces macrophagechea catheterized, and 4% formalin injected in order to fill the bron-
apoptosis by binding to Caspase-1. Proc. Natl. Acad. Sci. USA 96,cheoalveolar space. Lungs were then removed and fixed in 4%
2396±2401.formalin before being processed for histopathological studies. Ten-
micrometer paraffin sections were stained with H&E, and observed Hilbi, H., Moss, J.E., Hersh, D., Chen, Y., Arondel, J., Banerjee, S.,
with a BX50 Olympus microscope (Olympus Optical, Europa, GmbH, Flavell, R.A., Yuan, J., Sansonetti, P.J., and Zychlinsky, A. (1998).
Hamburg, Germany). To quantify the inflammatory response, the Shigella-induced apoptosis is dependent on caspase-1 which binds
microscopic images were scanned into a computer and analyzed to IpaB. J. Biol. Chem. 273, 32895±32900.
with NIH image software. The ratio of the surface of these areas to Islam, D., Veress, B., Bardhan, P.K., Lindberg, A.A., and Chris-
the entire surface of the tissue section minus the anatomic ªholesº, tensson, B. (1997). In situ characterization of inflammatory re-
i.e., the lumen of large blood vessels and bronchi, was computed sponses in the rectal mucosae of patients with Shigellosis. Infect.
as the ªinflammatory index.º The resulting inflammatory index was Immunol. 65, 739±749.
the median of at least 17 mice (range 17±24) in each group.
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